Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies

被引：4

作者：

Gressens, Simon B. ^{[1
]}

Wiedemann, Aurelie ^{[2
,4
]}

Dechenaud, Marie ^{[2
]}

Dupuis, Jehan ^{[3
]}

Gallien, Sebastien ^{[1
,4
]}

Melica, Giovanna ^{[1
,4
]}

Haioun, Corinne ^{[3
,4
]}

Lemonnier, Francois ^{[3
,4
]}

Levy, Yves ^{[1
,2
]}

机构：

[1] Univ Paris Est Creteil, Hop Univ Henri Mondor, AP HP, Infect Dis & Immunol Dept, Creteil, France

[2] Univ Paris Est Creteil, Vaccine Res Inst, Fac Med, Team 16,INSERM U955, Creteil, France

[3] Grp Hosp Univ Chenevier Mondor, Serv Unite Hemopathies Lymphoides, IAP HP, F-94010 Creteil, France

[4] Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France

来源：

VACCINE | 2023年 / 41卷 / 09期

关键词：

Third dose; COVID-19; Immunocompromised; Vaccine; T cell responses; Hematological malignancies; SARS-COV-2; IMMUNITY;

D O I：

10.1016/j.vaccine.2023.01.064

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients receiving anti-CD20 antibodies showed limited efficacy of a booster dose of BNT162b2. Patients with lymphomas combine such immunotherapies with cytotoxic chemotherapies that could result in an even greater alteration of the immune response to vaccination. We report here the impact of a third vac-cine dose on T cell specific responses in a small cohort of patients treated in our center by anti-CD20 ther-apies and cytotoxic chemotherapies for lymphoid malignancies. Our results showed that a third dose in these severely immune suppressed patients could improve the expansion on CD4+Th1+T cell responses while the effect CD8 + T cell responses was marginal. (c) 2023 Elsevier Ltd. All rights reserved.

引用

页码：1550 / 1553

页数：4

共 50 条

[1] Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies
Gressens, Simon B.
Fourati, Slim
Le Bouter, Anne
Le Bras, Fabien
Dupuis, Jehan
Hammoud, Mohammad
El Gnaoui, Taoufik
Gounot, Romain
Roulin, Louise
Belhadj, Karim
Haioun, Corinne
Gallien, Sebastien
Melica, Giovanna
Lemonnier, Francois
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) : 885.e7 - 885.e11
[2] Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
Salvagno, G. L.
Henry, B. M.
Lippi, G.
INFECTIOUS DISEASES NOW, 2022, 52 (06): : 379 - 380
[3] Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
Graceffa, Dario
Sperati, Francesca
Bonifati, Claudio
Spoletini, Gabriele
Lora, Viviana
Pimpinelli, Fulvia
Pontone, Martina
Pellini, Raul
Di Bella, Ornella
Morrone, Aldo
Cristaudo, Antonio
FRONTIERS IN MEDICINE, 2022, 9
[4] Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls
Eviatar, Tali
Pappo, Adi
Freund, Tal
Friedlander, Yishai
Elkayam, Ori
Hagin, David
Heshin-Bekenstein, Merav
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 217 (02) : 167 - 172
[5] Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
Laquintana, Valentina
Mottini, Carla
Marchesi, Francesco
Marcozzi, Benedetta
Terrenato, Irene
Sperandio, Eleonora
de Latouliere, Luisa
Carrieri, Francesca
Pimpinelli, Fulvia
Pontone, Martina
Pellini, Raul
Campo, Flaminia
Conti, Laura
Accetta, Celeste
Mandoj, Chiara
Petrone, Fabrizio
Di Bella, Ornella
Vujovic, Branka
Morrone, Aldo
Compagnone, Mirco
Principato, Eugenia
Pinto, Eleonora
Papa, Elena
Falcucci, Paolo
La Malfa, Antonia
Pallocca, Matteo
De Marco, Federico
Piaggio, Giulia
Ciliberto, Gennaro
Mengarelli, Andrea
di Martino, Simona
FRONTIERS IN IMMUNOLOGY, 2024, 14
[6] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
Lo Sasso, Bruna
Giglio, Rosaria Vincenza
Vidali, Matteo
Scazzone, Concetta
Bivona, Giulia
Gambino, Caterina Maria
Ciaccio, Anna Maria
Agnello, Luisa
Ciaccio, Marcello
DIAGNOSTICS, 2021, 11 (07)
[7] Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant
Le Bourgeois, Amandine
Coste-Burel, Marianne
Guillaume, Thierry
Peterlin, Pierre
Garnier, Alice
Imbert, Berthe-Marie
Drumel, Thomas
Mahe, Beatrice
Dubruille, Viviane
Blin, Nicolas
Lok, Anne
Touzeau, Cyrille
Gastinne, Thomas
Tessoulin, Benoit
Jullien, Maxime
Vantyghem, Sophie
Moreau, Philippe
Le Gouill, Steven
Bene, Marie C.
Chevallier, Patrice
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (05) : E38 - E40
[8] Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy
Gastinne, Thomas
Le Bourgeois, Amandine
Coste-Burel, Marianne
Guillaume, Thierry
Peterlin, Pierre
Garnier, Alice
Imbert, Berthe-Marie
Drumel, Thomas
Mahe, Beatrice
Dubruille, Viviane
Blin, Nicolas
Lok, Anne
Touzeau, Cyrille
Tessoulin, Benoit
Jullien, Maxime
Vanthygem, Sophie
Bene, Marie C.
Moreau, Philippe
Le Gouill, Steven
Chevallier, Patrice
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 360 - 362
[9] MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
Caroline Boulouis
Tobias Kammann
Angelica Cuapio
Tiphaine Parrot
Yu Gao
Elli Mouchtaridi
David Wullimann
Joshua Lange
Puran Chen
Mira Akber
Olga Rivera Ballesteros
Jagadeeswara Rao Muvva
C. I. Edvard Smith
Jan Vesterbacka
Oscar Kieri
Piotr Nowak
Peter Bergman
Marcus Buggert
Hans-Gustaf Ljunggren
Soo Aleman
Johan K. Sandberg
Molecular Medicine, 2022, 28
[10] MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
Boulouis, Caroline
Kammann, Tobias
Cuapio, Angelica
Parrot, Tiphaine
Gao, Yu
Mouchtaridi, Elli
Wullimann, David
Lange, Joshua
Chen, Puran
Akber, Mira
Ballesteros, Olga Rivera
Muvva, Jagadeeswara Rao
Smith, C. I. Edvard
Vesterbacka, Jan
Kieri, Oscar
Nowak, Piotr
Bergman, Peter
Buggert, Marcus
Ljunggren, Hans-Gustaf
Aleman, Soo
Sandberg, Johan K.
MOLECULAR MEDICINE, 2022, 28 (01)

← 1 2 3 4 5 →